Looser restrictions on GSK drug Avandia endorsed by FDA panel

06/6/2013 | Forbes · Wall Street Journal, The · Washington Post, The

Twenty of 26 members of an FDA advisory panel voted Thursday to relax or erase restrictions on GlaxoSmithKline's diabetes drug Avandia. The agency will consider whether to act on the recommendations. The FDA remains interested in pressing drugmakers to produce as much data from clinical studies as possible, but the agency appears less jittery about the possibility of controversy about drug risks, Matthew Herper writes for Forbes.

View Full Article in:

Forbes · Wall Street Journal, The · Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA